Covered recipient · General Payments record
CATHERINE EVANS POSTON
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$1,810.00
- Reported across 126 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $429.55 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $135.26 | 10 |
| Novo Nordisk AS | $81.06 | 4 |
| GlaxoSmithKline, LLC. | $40.11 | 2 |
| PFIZER INC. | $34.58 | 2 |
| Acerta Pharma LLC | $28.18 | 2 |
| Otsuka America Pharmaceutical, Inc. | $22.70 | 1 |
| Kedrion Biopharma, Inc. | $22.41 | 1 |
| SANOFI-AVENTIS U.S. LLC | $21.28 | 1 |
| Merck Sharp & Dohme Corporation | $15.54 | 1 |
| Amgen Inc. | $14.42 | 1 |
| Exact Sciences Corporation | $14.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.73 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108032542 | CMS |
| ABBVIE INC. | $13.63 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108032544 | CMS |
| ABBVIE INC. | $20.54 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108032546 | CMS |
| ABBVIE INC. | $10.55 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108032548 | CMS |
| ABBVIE INC. | $15.33 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108032550 | CMS |
| ABBVIE INC. | $10.21 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108032552 | CMS |
| ABBVIE INC. | $14.40 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108032554 | CMS |
| ABBVIE INC. | $11.30 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108032556 | CMS |
| ABBVIE INC. | $14.32 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108032558 | CMS |
| ABBVIE INC. | $11.25 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108032560 | CMS |
| Amgen Inc. | $14.42 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117658326 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.87 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105827099 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.31 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105854362 | CMS |
| Exact Sciences Corporation | $14.01 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114454679 | CMS |
| GlaxoSmithKline, LLC. | $20.40 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116228049 | CMS |
| GlaxoSmithKline, LLC. | $19.71 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116647141 | CMS |
| Kedrion Biopharma, Inc. | $22.41 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125860933 | CMS |
| Merck Sharp & Dohme LLC | $15.54 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141955495 | CMS |
| Novo Nordisk Inc | $16.57 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100600563 | CMS |
| Novo Nordisk Inc | $22.69 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100243733 | CMS |
| Novo Nordisk Inc | $25.45 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100620106 | CMS |
| Novo Nordisk Inc | $16.35 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100295170 | CMS |
| Otsuka America Pharmaceutical, Inc. | $22.70 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119164854 | CMS |
| PFIZER INC. | $15.70 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131856078 | CMS |
| PFIZER INC. | $18.88 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131105262 | CMS |
| SANOFI-AVENTIS U.S. LLC | $21.28 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139886346 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.